ITEM 2.02. Results of Operations and Financial Condition.

On November 9, 2012, NPS Pharmaceuticals, Inc. issued a press release announcing its operating results for the third quarter of 2012. The text of the press release is furnished as Exhibit 99.1 to this Form 8-K.

The information in Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

ITEM 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Press Release issued by NPS Pharmaceuticals, Inc. on November 9, 2012.

---